Skip to main content

Table 1 Demographics and outcomes (n = 103 subjects)

From: Underdiagnoses of Rickettsia in patients hospitalized with acute fever in Indonesia: observational study results

Median age (range) y.o.35 (1–75)
Male: female69: 34
Distribution of cases in age groupa, N(%)
 1 - ≤5 years2/153 (1.3%)
 6 - ≤18 years19/190 (10%)
 19 - ≤45 years53/378 (14%)
 > 45 years29/254 (11.4%)
Day of onset (median, range), days5 (1–12)
Length of stay (median, range), days6 (1–36)
Antibiotics use from 90 subjects with documented history, N (%)76 (84%)
 Ceftriaxone17 (22.4%)
 Ciprofloxacin9 (11.8%)
 Levofloxacin9 (11.8%)
 Cefixime2 (2.6%)
 Cefotaxime, Amoxicillin, Ampicillin, Cefadroxil, Meropenem, Chloramphenicol, Cefoperazone, Sulbactam, Cotrimoxazole1 (1.3%), each
 Combination 2–3 antibiotics30 (39.5%)
Outcomes, N (%)
 Recovered72 (69.9%)
 Recovered with sequelaeb24 (23.3%)
 Died7 (6.8%)
By sitesa, N (%)
 Bandung22/189 (11.6%)
 Denpasar16/101 (15.8%)
 Jakarta7/87 (8%)
 Makassar5/131 (3.8%)
 Semarang21/191 (10.9%)
 Surabaya26/156 (16.7%)
 Yogyakarta6/120 (5%)
  1. afrom 975 subjects tested for Rickettsia typhi
  2. bLethargy, arthralgia, anorexia, headache, dizziness, cough